U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07502235) titled 'The Effect of Lactoferrin on Pain Management Following Cesarean Section' on March 25.
Brief Summary: This study evaluates whether lactoferrin, a naturally occurring protein with anti-inflammatory and antioxidant properties, can improve pain control after cesarean section. Effective management of postoperative pain is essential to support maternal recovery, mobility, and the ability to care for the newborn, while minimizing reliance on opioid medications and their associated side effects.
In this randomized, double-blind, placebo-controlled trial, women undergoing elective cesarean section will receive either oral lactoferrin or a ...